Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

NCT04673175 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Due to slow accrual.

Conditions

Pneumonia
Hematologic Malignancy
Pseudomonas Aeruginosa Infection
Bacteremia
Hematopoietic Stem Cell Transplant (HSCT)

Interventions

DRUG: Ceftolozane / Tazobactam Injection

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]